Surviving blood loss without fluid resuscitation

Journal of Trauma - Injury, Infection and Critical Care

Volumn 64, Issue 3, 2008, Pages 629-638

  Shults, Christian ^a,b   Sailhamer, Elizabeth A ^a   Li, Yongqing ^a   Liu, Baoling ^a   Tabbara, Malek ^a   Butt, Muhammad Umar ^a   Shuja, Fahad ^a   DeMoya, Marc ^a   Velmahos, George ^a   Alam, Hasan B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

HDAC inhibitors; Hemorrhagic shock; Histone acetylation; Pharmacologic resuscitation; Resuscitation; SAHA; Survival; Transcription; Valproic acid

Indexed keywords

DNA; HISTONE H3; SODIUM CHLORIDE; VALPROIC ACID; VORINOSTAT;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MECHANISM; FLUID RESUSCITATION; HEMODYNAMIC PARAMETERS; HEMORRHAGIC SHOCK; MALE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SURVIVAL RATE;

ANALYSIS OF VARIANCE; ANIMALS; CHI-SQUARE DISTRIBUTION; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SHOCK, HEMORRHAGIC; VALPROIC ACID;

EID: 40549102144     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181650ff3     Document Type: Article

References (38)

1. Champion HR, Bellamy RF, Roberts CP, Leppaniemi A. A profile of combat injury. J Trauma. 2003;54(suppl):S13-S19.
2. Pope A, French G, Longnecker DE. Fluid Resuscitation: State of the Science for Treating Combat Casualties and Civilian Injuries. Washington DC, Institute of Medicine, National Academy Press; 1999.
3. Alam HB. An update on fluid resuscitation. Scand J Surg. 2006;95:136-145.
4. Peake JB. Beyond the purple heart - continuity of care for the wounded in Iraq. N Engl J Med. 2005;352:219-222.
5. Chambers LW, Rhee P, Baker BC, et al. Initial experience of US Marine Corps Forward Resuscitative Surgical System during Operation Iraqi Freedom. Arch Surg. 2005;140:26-32.
6. Patel TH, Wenner KA, Price SA, et al. A US Army Forward Surgical Team's experience in Operation Iraqi Freedom. J Trauma. 2004;57:201-207.
7. Rush RM, Stockmaster NR, Stinger HK, et al. Supporting the global war on terror: a tale of two campaigns featuring the 250th Forward Surgical Team (Airborne). Am J Surg. 2005;189:564-570.
8. Pusateri AE, Holcomb JB, Kheirabadi BS, Alam HB, Wade CE, Ryan KL. Making sense of the preclinical literature on advanced hemostatic products. J Trauma. 2006;60:674-682.
9. Alam HB, Burris D, DaCorta JA, Rhee P. Hemorrhage control in the battlefield: role of new hemostatic agents. Mil Med. 2005;170:63-69.
10. Alam HB, Stegalkina S, Rhee P, Koustova E. cDNA array analysis of gene expression following hemorrhagic shock and resuscitation in rats. Resuscitation. 2002;54:195-206.
11. Chen H, Alam HB, Querol RILC, Rhee P, Li Y, Koustova E. Identification of expression patterns associated with hemorrhage and resuscitation: integrated approach to data analysis. J Trauma. 2006;60:701-724.
12. Alam HB. Rhee P. New developments in fluid resuscitation. Surg Clin North Am. 2007;87:55-72.
13. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007;128:669-681.
14. Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007;128:635-638.
15. Jenuwein T, Allis CD. Translating the histone code. Science. 2001; 293:1074-1080.
16. Thiagalingam S, Cheng K, Lee HJ, Mineva N, Thiagalingam A, Ponte JF. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann NY Acad Sci. 2003;983:84-100.
17. Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693-705.
18. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deasetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370:737-749.
19. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell. 2004;116:259-272.
20. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell. 2007;128:707-719.
21. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1999;389:349-352.
22. Marks PA, Miller T, Richon VM. Histone deasetylases. Curr Opin Pharm. 2003;3:344-351.
23. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 2000;19:1176-1179.
24. Lin T, Alam HB, Chen H, Britten-Webb J, Rhee P, Kirkpatrick J, Koustova E. Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation. Surgery. 2006;139:365-376.
25. Alam HB, Shults C, Ahuja N, Ayuste EC, et al. Impact of resuscitation strategies on the acetylation status of cardiac histones in a swine model of hemorrhage. Resuscitation. 2008; 76:299-310.
26. Lin T, Chen H, Koustova E, et al. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver. Surgery. 2007;141:784-794.
27. Gonzales E, Chen H, Munuve R, Mehrani T, et al. Hepatoprotection and lethality rescue by the histone deacetylase inhibitor valproic acid. J Trauma. 2006;2:516 (abstract).
28. Gonzales E, Chen H, Munuve R, et al. Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones. Shock. 2006;25:395-401.
29. Dokmanovic M, Marks PA. Prospects: histone deacetylase inhibitors. J Cell Biochem. 2005;96:293-304.
30. Ryu H, Lee J, Oloffson BA, et al. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci. 2003;100:4281-4286.
31. Steffan JS, Bodal L, Pallos J, et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurogeneration in Drosophila. Nature. 2001;413:739-743.
32. Chang KT, Min KT. Regulation of lifespan by histone deacetylase. Ageing Res Rev. 2002;1:313-326.
33. Leoni F, Zaliani A, Bertolini G, et al. The anti-tumor histone deacetylase inhibitor suberoyanilide hydroxamic acid exhibit antiinflammatory properties via suppression of cytokine. Proc Natl Acad Sci. 2002;99:2995-3000.
34. Kelly WK, Marks PA. Drug insight: Histone deacetylase inhibitors-development of the new targeted anti-cancer agent suberoyanilide hydroxamic acid. Nat Clin Pract Oncol. 2005;2:150-157.
35. Karagiannis TC, El-Osta A. Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds? Leukemia. 2007;21:61-65.
36. Glozak M, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of non-histone proteins. Gene. 2005;363:15-23.
37. Wheless JW, Vazquez BR, Kanner AM, Ramsay RE, Morton L, Pellock JM. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology. 2004;63:1507-1508.
38. Kumar P, Vallis CJ, Hall CM. Intravenous valproate associated with circulatory collapse. Ann Pharmacother. 2003;7:1797-1799.